 |
|
|
| |
Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Edward Gane,1 Yang Zhao,2 Susanna K. Tan,2 Audrey H. Lau,2 Anuj Gaggar,2 Mani Subramanian,2 Jeffrey Wallin,2 Anna E. Brooks,3 P. Rod Dubar,3 Shyam Kottilil,4 Lydia Tang4
1Auckland City Hospital, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA; 3The University of Auckland, Auckland, New Zealand; 4University of Maryland School of Medicine, Baltimore, MD
|
| |
|
|
|
|
|
